BioRestorative Therapies Inc.
BRTX | NASDAQ
$2.71
+$0.02 (+0.74%)
At close: Sep 21, 2026, 4:00 PM ET
$2.71
$0 (+0.02%)
Pre-market:
Sep 22, 2026, 9:16 AM ET
Market Data
Market Cap $3.74M
Enterprise Value $185.34K
Beta 0.74
Average Volume 46.3K
Shares Outstanding (Diluted) 886.39K
Shares Change YoY 112.13%
Institutional Ownership 4.34%
Exchange NASDAQ
ISIN US0906556065
Price Performance
Price Change 1M -38.0%
Price Change 3M -64.7%
Price Change 6M -56.3%
Price Change YTD -88.9%
Price Change 1Y -90.8%
Price Change 3Y -91.8%
Price Change 5Y -99.0%
1M CAGR (ann.) -33.6%
1Y CAGR (ann.) -90.7%
5Y CAGR (ann.) -60.5%
All-Time CAGR -63.1%
Valuation
PE Ratio -0.12
Forward PE N/A
PEG Ratio -0.01
Forward PEG 0.01
PS Ratio 10.46
Forward PS 1.20
PB Ratio 1.24
P/FCF Ratio -0.31
P/Adj. FCF Ratio -0.28
P/OCF Ratio -0.20
EV/Sales 0.52
EV/EBIT -0.02
EV/EBITDA -0.02
EV/FCF -0.02
Earnings Yield -819.2%
FCF Yield -317.9%
Adj. FCF Yield -360.8%
Financial Health
Net Cash $3.56M
Total Debt $34.52K
Cash & Short-Term Investments $3.59M
Total Assets $4.64M
Current Ratio 2.35
Quick Ratio 2.35
Debt / Equity Ratio 0.01
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt -342.40
Interest Coverage 0.00
Altman Z-Score -57.75
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 92.1%
Operating Profit Margin -3975.0%
EBITDA Margin -3030.7%
Net Profit Margin -3089.6%
FCF Margin -3324.6%
Adj. FCF Margin -3773.5%
SBC / Revenue 449.0%
SBC Impact (per share) -13.5%
Returns
Return on Assets -238.3%
Return on Equity -423.8%
Return on Invested Capital -464.9%
Return on Capital Employed -470.2%
Return on Tangible Assets -267.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 38.4%
Revenue CAGR 5Y 39.0%
Revenue CAGR 10Y -2.3%
EPS CAGR 3Y 2.0%
EPS CAGR 5Y 68.3%
EPS CAGR 10Y 41.1%
FCF CAGR 3Y -28.6%
FCF CAGR 5Y -22.1%
FCF CAGR 10Y -11.1%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y 21.9%
Revenue Growth Next 3Y 125.9%
Earnings Date Sep 21, 2026
EPS Estimate (next Q) -$2
EPS Growth Est (next Q) N/A
Revenue Est (next Q) $600K
Revenue Growth Est (next Q) 97.8%
Cash Flow
Operating Cash Flow $-11.82M
Free Cash Flow $-11.9M
Adj. Free Cash Flow $-13.5M
FCF Per Share -$13.42
OCF Per Share -$13.33
OCF/S Ratio -3302.3%
Income Statement
Revenue $357.87K
Gross Profit $329.55K
Operating Income $-14.23M
EBITDA $-10.85M
Net Income $-11.06M
EPS (Diluted) -$22.20
Revenue / Employee $32.53K
Profit / Employee $-1.01M
Employees 11
Add to Watchlist
Select watchlists to add or remove BRTX